Market Jim Cramer explains why it’s hard to own usual ‘safety’ stocks hereBy adminMay 14, 20250 CNBC’s Jim Cramer reviewed why certain stocks that are usually considered safe bets — like pharmaceuticals or consumer packaged goods…
Market Goldman adds J&J to its ‘conviction list.’ Here’s who else is on itBy adminMay 1, 20250 Goldman Sachs named pharmaceutical giant Johnson & Johnson to its “U.S. Conviction List – Directors’ Cut” of the most recommended…
